Bladder Cancer and Probiotics: What Do We Know So Far?

ABSTRACT: Bladder cancer is around the 10th most diagnosed cancer, although has a considerable mortality. Recent research and new methodologies have discarded the historical dogma that the bladder (and urine) was sterile under normal conditions. Specifically, only a few studies have reported a detailed analysis of the urinary microbiota in patients with bladder cancer, thus exhibiting a remarkable variability due to the low biomass of the urinary microbiota and the influence of many factors. Nevertheless, this research shows us signals that urinary microbiota is a factor to be considered in the pathophysiology of bladder cancer. More importantly, probiotics could be useful as an adjuvant therapy to reduce the recurrence rate or increase the disease-free period after surgery. In vitro studies and ani

SUBMITTER: Sanchez-Pellicer P 

PROVIDER: S-EPMC10705339 | biostudies-literature | 2023 Nov

REPOSITORIES: biostudies-literature